Brief: Biofrontera Inc. Reports Third Quarter 2022 Financial Results, Provides A Business Update
14/11/2022 18:28
Nov 14 (Reuters) - Biofrontera Inc BFRI.O :
* BIOFRONTERA INC. REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES A BUSINESS UPDATE
* BIOFRONTERA INC - QTRLY LOSS PER SHARE $0.11
* BIOFRONTERA INC - REVISING ITS PREVIOUSLY ANNOUNCED
FINANCIAL
GUIDANCE FOR 2022
* BIOFRONTERA INC - CASH AND CASH EQUIVALENTS WERE $27.5
MILLION
AS OF SEPTEMBER 30, 2022, COMPARED WITH $24.5 MILLION AS OF
DECEMBER 31, 2021
Source text for Eikon: ID:nGNXc7DQ61
Further company coverage: BFRI.O
Recent news on Biofrontera
See all newsBrief: Biofrontera Submits Supplemental New Drug Application To FDA To Expand Ameluz® Red Light Pdt To Actinic Keratoses On The Full Body
Biofrontera Inc reports results for the quarter ended June 30 - Earnings Summary
Biofrontera Q2 revenue rises on higher volume, pricing
Biofrontera Inc expected to post a loss of 10 cents a share - Earnings Preview
Biofrontera Q1 revenue rises on higher Ameluz sales